E Fund Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103K | Buy |
28,273
+8,962
| +46% | +$32.6K | ﹤0.01% | 375 |
|
|
2025
Q1 | $37.1K | Buy |
19,311
+6,595
| +52% | +$12.7K | ﹤0.01% | 395 |
|
|
2024
Q4 | $24.2K | Buy |
+12,716
| New | +$24.2K | ﹤0.01% | 394 |
|
|
2022
Q2 | – | Sell |
-35,250
| Closed | -$25K | – | 324 |
|
|
2022
Q1 | $25K | Buy |
35,250
+10,853
| +44% | +$7.7K | ﹤0.01% | 325 |
|
|
2021
Q4 | $55K | Sell |
24,397
-12,726
| -34% | -$28.7K | ﹤0.01% | 296 |
|
|
2021
Q3 | $107K | Buy |
+37,123
| New | +$107K | ﹤0.01% | 258 |
|
|
2021
Q1 | $130K | Buy |
+38,410
| New | +$130K | 0.01% | 229 |
|